Status:
UNKNOWN
Gastrointestinal Symptoms in COVID-19
Lead Sponsor:
University of Bologna
Conditions:
COVID19 Disease
Eligibility:
All Genders
18-85 years
Brief Summary
The coronavirus disease 2019 (COVID-19) initially developed at the beginning of December 2019 in Whuan, Hubei province of China has spread all over the world. Beside the most common symptoms at onset ...
Detailed Description
The investigators propose a multicentre observational prospective study according to the clinical routine practice of coronavirus disease 2019 (COVID-19) patients. All patients will be clinically eval...
Eligibility Criteria
Inclusion
- Signed informed consent
- Age ≥18 years and ≤85 years
- Consecutive COVID19 confirmed patients (COVID +ve) (case group)
- Consecutive hospitalized COVID19 negative patients (COVID -ve) (control group)
- Ability to conform to study protocol
Exclusion
- Patients under mechanical ventilation
- Patients unable to report required data
- Current diagnosis of cancer
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04691895
Start Date
May 1 2020
End Date
December 31 2021
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138